Home About Events Press Room Contact Login
Global Insight // Bringing You the Power of Perspective
Healthcare & Pharma Industry Analysis
World Markets Healthcare
Generics Analysis
Pharmaceutical Pricing and Reimbursement Services
Oncology Pricing and Reimbursement Analysis
U.S. Healthcare Cost Service
European Pharmaceutical Market Data and Research
Healthcare Custom Solutions

Related Highlights
  Successfully developing strategies for distributing drugs to pharmacies in Europe
  How to develop strategies for distribution of drugs throughout hospitals in Europe
  How should Pharmaceutical Companies position themselves to handle the threat posed by biosimilars?
  Looking Back to the Future in the Global Pharma Market: Wrap-Up of 2007, Outlook for 2008


Global Insight's Healthcare and Pharmaceuticals practice provides an independent, comprehensive range of analysis, forecasts, data, and consulting services for:
  • Pharmaceutical manufacturers, wholesalers, and distributors
  • Biotechnology research and development firms
  • Generics manufacturers
  • Healthcare policy makers and regulatory bodies
  • Healthcare providers and insurers
  • Financial institutions and professional services organizations
We can provide you with timely, insightful, and accurate analysis on the evolving regulatory and competitive landscape in more than 60 countries worldwide—enabling you to:
  • Evaluate market opportunities and risks
  • Monitor competitors and customers
  • Assess the impact of a changing regulatory environment
  • Plan and forecast budgets
  • Stay up to date with recent industry developments and market trends
With our unique global perspective and regional expertise, we understand the forces in play—healthcare policy and regulatory developments, pharmaceutical pricing and reimbursement, industry-wide corporate strategies, and research and development trends,— and the ways they interact to influence your market opportunities.

Products and Services

Global Insight Healthcare and Pharmaceuticals Experts

Our expert team provides an independent, fact-based view of the healthcare and pharmaceutical industry, fully supported by our 325+ economists and analysts worldwide with expertise in over 120 industries and 200 countries.

Global Insight is the world leader in economic and financial analysis, forecasting, and market intelligence—with more than 40 years' experience and an outstanding record for accuracy.




Perspectives
18 Nov 08
Wyeth's Relistor, GSK's Volibris Among 11 Drugs Recommended for Approval by ADEC


17 Nov 08
Mexican Price-Negotiation Commission Reaches Agreement with Canifarma


14 Nov 08
China to Start Public Hospital Reform Trial, Guangdong Proposes to Pioneer


13 Nov 08
The New U.S. Government's Plans for the Pharma/Healthcare Industry


More 

International Web Site: Japan
 Copyright ©2008 GLOBAL INSIGHT, Inc. Site Map  •  Terms of Use  •  Privacy Policy